文献速递关节外科

预测初次全髋与全膝关节置换术后阿片类药物未暴露患者的出院后阿片类药物消耗

Predicting Post-Discharge Opioid Consumption After Total Hip and Knee Arthroplasty in the Opioid-Naïve Patient.
PubMed 文献 · J Arthroplasty · 2022-02-11

单机构前瞻性队列研究纳入243例因骨关节炎行初次全髋(123例)或全膝(120例)关节置换的阿片类药物未暴露患者,术前完成PROMIS-29与疼痛灾难化量表,术后12周每周调查阿片消耗(MME)、停药时间与疼痛评分。多变量回归显示仅术前疲劳T评分与术后阿片使用时长及全膝置换阿片消耗量相关,其他PROMIS-29域及疼痛灾难化量表无显著关联。

要点

  • 全髋置换平均阿片消耗75.1±112.0 MME、持续1.7±1.7周;全膝置换384.7±473.3 MME、持续4.3±3.5周。
  • 术前PROMIS-29疲劳T评分每增加1分,全髋阿片使用延长8.4小时(P=.008),全膝延长15.1小时(P=.036)并额外消耗12.7 MME(P=.027)。
  • 其他PROMIS-29域及疼痛灾难化量表与术后阿片消耗无显著关联。

核心结论

  • 全髋与全膝置换术后阿片使用时长不同,且可能与疼痛评分相关;仅术前疲劳与术后阿片消耗相关,这些发现可为术后疼痛管理路径提供信息。

研究设计与样本

  • 单机构前瞻性队列研究,纳入243例因骨关节炎行择期初次全髋(n=123)或全膝(n=120)关节置换的阿片类药物未暴露患者。

主要发现

  • 全髋置换平均总阿片消耗75.1±112.0 MME、持续1.7±1.7周;全膝置换384.7±473.3 MME、持续4.3±3.5周。
  • 停药后视觉模拟疼痛评分(0-100)全髋为28.0±22.9,全膝为30.7±25.8。
  • 术前PROMIS-29疲劳T评分每增加1分,全髋阿片使用延长8.4小时(P=.008),全膝延长15.1小时(P=.036)并额外消耗12.7 MME(P=.027)。
  • 其他PROMIS-29域及疼痛灾难化量表与术后阿片消耗无显著关联。

关键数值与推荐

  • 术前评估工具包括PROMIS-29(患者报告结局测量信息系统,涵盖身体功能/焦虑/抑郁/疲劳/睡眠障碍/社会活动/疼痛干扰/疼痛强度)与疼痛灾难化量表。
  • 术后12周内每周调查吗啡毫克当量(MME)阿片消耗、停药时间与视觉模拟疼痛评分。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pain catastrophizing, anxiety, and depression are associated with poor outcomes after total hip (THA) and total knee (TKA) arthroplasty. The goal of this study is to determine the relationship between post-operative pain scores and opioid consumption; and the association among pre-operative measures of anxiety, depression, and pain catastrophizing and post-operative opioid consumption in patients undergoing THA and TKA. METHODS: This is a single-institution prospective cohort study of 243 opioid-naïve patients undergoing elective, primary THA (n = 123) or TKA (n = 120) for osteoarthritis. Pre-operatively, patients completed the PROMIS-29 (Patient-Reported Outcomes Measures Information System; physical function/anxiety/depression/fatigue/sleep disturbance/social activities/pain interference/pain intensity) and Pain Catastrophizing Scale. Post-operatively, patients completed a weekly survey for 12 weeks determining morphine-milligram-equivalent (MME) opioid consumption, opioid cessation, and visual analog scale pain scores. Multivariable regression models determined the association between pre-operative scores and post-operative opioid consumption. RESULTS: Mean (±standard deviation) total opioid consumption and duration was 75.1 ± 112.0 MME and 1.7 ± 1.7 weeks in THA and 384.7 ± 473.3 MME and 4.3 ± 3.5 weeks in TKA. Visual analog scale pain scores (0-100) after opioid cessation were 28.0 ± 22.9 in THA and 30.7 ± 25.8 in TKA. Multivariable regression showed that each unit increase in PROMIS-29 fatigue T-score was associated with 8.4 hours longer opioid usage in THA (P = .008) and 15.1 hours longer in TKA (P = .036), as well as 12.7 MME additional opioids in TKA (P = .027). There were no significant associations with other PROMIS-29 domains or the Pain Catastrophizing Scale. CONCLUSION: Opioid use duration is different for THA and TKA and may correlate with pain scores. Only pre-operative fatigue was associated with post-operative opioid consumption. These findings should inform THA and TKA post-operative pain management pathways.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Debbi EM, Krell EC, Sapountzis N, et al. Predicting Post-Discharge Opioid Consumption After Total Hip and Knee Arthroplasty in the Opioid-Naïve Patient. J Arthroplasty. 2022. PMID: 35151806. doi:10.1016/j.arth.2022.02.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。